Skip to content

Clinical trials

Angina Pectoris trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Angina Pectoris Country / region: China Clear all

26 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20091
20101
20125
20132
20142
20152
20161
20171
20193
20214
20231
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Unknown status10
Not yet recruiting2
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Beijing Anzhen Hospital3
China Academy of Chinese Medical Sciences2
China National Center for Cardiovascular Diseases2
Shanghai Hutchison Pharmaceuticals Limited2
Affiliated Hospital to Academy of Military Medical Sciences1
AstraZeneca1
BIOTRONIK Asia Pacific Pte Ltd1
Bayer1
Changchun University of Chinese Medicine1
Chengdu University of Traditional Chinese Medicine1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Angina Pectoris26
Coronary Artery Disease10
Coronary Disease8
Myocardial Infarction5
Myocardial Ischemia5
Heart Diseases3
Angina, Stable2
Arteriosclerosis2
Cardiovascular Diseases2
Chest Pain2

Trials

Showing 76 to 26 of 26. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.